Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Poseida Therapeutics, Inc. PSTX

Set alert

Price alert · PSTX

All alert types
9.50 0.00 0.00%

At close · Jan 7

9.50 Day range 9.58

52-week range unavailable

YTD
-1.04%
1 year
+178.59%
Open
9.58
Prev close
9.50
Mkt cap
925.93M
Vol
21.34M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
9.50
High
9.58
Forward P/E
-5.64
Beta
0.54
Short ratio
2.05
Inst. own
58.44%
Dividend
0.00
Ex-div date
Earnings
Aug 5, 2024
50-d avg
5.12
200-d avg
3.48
1y target
9.50

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 30, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 7, 2024Earnings: 0.21; estimate -0.42; surprise 150%
  • Nov 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 26, 2024Downgrade: HC Wainwright & Co. · Buy → Neutral
  • Nov 26, 2024Downgrade: William Blair · Outperform → Market Perform
  • Nov 26, 2024Downgrade: BTIG · Buy → Neutral
Signals (14)
NameDateAgo
MACD: Sell SignalDec 17, 20241 year ago
MACD: Buy SignalNov 26, 20241 year ago
RSI: OverboughtNov 26, 20241 year ago
SMA: BullishNov 25, 20241 year ago
SMA: BullishNov 19, 20241 year ago
MACD: Sell SignalNov 19, 20241 year ago
SMA: BearishNov 18, 20241 year ago
SMA: BearishNov 15, 20241 year ago
RSI: OverboughtNov 8, 20241 year ago
SMA: BullishNov 6, 20241 year ago
SMA: BullishNov 5, 20241 year ago
MACD: Buy SignalOct 28, 20242 years ago
MACD: Sell SignalOct 25, 20242 years ago
MACD: Buy SignalOct 23, 20242 years ago

Analyst view

Consensus: hold

Hold
Price target (mean) 9.50 0.0% upside
Target (low)
9.00
Target (mean)
9.50
Target (high)
10.00
Ratings (0m) 5 0 buy · 5 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold5
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5
  • 3 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PSTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.35667-0.50 – -0.28-0.27-32.1%21.25M-15.0%3
Next quarter-0.46667-0.65 – -0.29-0.25-86.7%7.50M-73.4%3
Current year-0.72667-0.87 – -0.65-1.37+47.0%147.11M+127.4%3
Next year-1.80-2.10 – -1.29-0.72667-148.2%43.33M-70.5%3

Upgrades and downgrades

The latest rating changes

PSTX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 26, 2024BTIGDowngradeBuyNeutral
Nov 26, 2024William BlairDowngradeOutperformMarket Perform
Nov 26, 2024HC Wainwright & Co.DowngradeBuyNeutral
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 2, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 11, 2023Piper SandlerMaintainedOverweightOverweight
Dec 11, 2023HC Wainwright & Co.MaintainedBuyBuy
Oct 10, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 23, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2023HC Wainwright & Co.Reiterated—Buy
Mar 10, 2023HC Wainwright & Co.Reiterated—Buy
Feb 23, 2023HC Wainwright & Co.Maintained—Buy
Feb 1, 2023Cantor FitzgeraldReiterated—Overweight
Jan 4, 2023HC Wainwright & Co.Initiated—Buy
Aug 9, 2022Piper SandlerMaintained—Overweight
May 13, 2022Piper SandlerMaintained—Overweight
Jan 7, 2022Cantor FitzgeraldInitiated—Overweight
May 18, 2021BTIGInitiated—Buy
Aug 4, 2020B of A SecuritiesInitiated—Buy
Aug 4, 2020Piper SandlerInitiated—Overweight